skip to Main Content

Advisory Board

Rosemary Coates

Rosemary Coates, MBA

Rosemary Coates is the President of Blue Silk Consulting and the Executive Director of the non-profit Reshoring Institute. She is an Best Selling author with five books on supply chain and operations management including: “42 Rules for Sourcing and Manufacturing in China,” and “Legal Blacksmith – How to Avoid and Defend Supply Chain Disputes.”  She has been a management consultant for over 25 years with nearly 80 clients worldwide. Ms. Coates earned an MBA from University of San Diego and a BS in Business Logistics from Arizona State University.  She teaches Global Supply Chain Strategies and Architectures, part time, at UC Berkeley.

Richard McKay

Richard McKay, PhD

Rich McKay is President and founder of Full Spectrum Scientific, a consulting company that delivers customized solutions for clients in the life sciences, helping them gain scientific and commercial traction for their novel technologies. Dr. McKay has worked for companies small and large: from startups developing single-molecule sequencing technologies, to GE Healthcare, where he developed imaging instrumentation for digital pathology and high-throughput cell based screening. Dr. McKay’s PhD work was in G protein mediated signaling in Drosophila and he did his postdoc at NIH where he studied mammalian calcium signaling.


Sean K. Murphy, MS

Sean Murphy is CEO of SKMurphy, Inc., a strategic advisory firm based in Silicon Valley that specializes in market creation and new technology product introduction. Prior to SKMurphy, Mr. Murphy has worked for Cisco Systems, 3Com, and AMD in a variety of engineering management, marketing, and business development roles. He holds a BS in Mathematical Sciences and an MS in Engineering-Economic Systems from Stanford University.


David Schodin, JD, PhD

David Schodin, JD, PhD, served as Director, Business Development & Licensing for Abbott Molecular, a division of Abbott Laboratories, where he led a team responsible for forming strategic and tactical collaborations with academic institutions and other companies, including new asset evaluations, access, and IP Licensing, with a focus on Oncology. Prior to this position, Mr. Schodin was a patent attorney with experience both at Abbott Laboratories and in the premier boutique IP law firm, Leydig, Voit & Mayer. Mr. Schodin’s PhD is in biochemistry from the University of Illinois, where Mr. Schodin conducted ten years of basic molecular biology and gene expression research.


János Szöllősi, PhD

János Szöllősi is Professor of Biophysics and Cell Biology at University of Debrecen, Hungary. Dr. Szöllősi has been playing a crucial role in developing and improving cell biological applications of fluorescence resonance energy transfer (FRET)-based techniques. In his research he uses flow and image cytometric approaches extensively. He is currently involved in cancer research, focusing on tyrosine kinase signal transduction and the role of cancer stem cells in cancer resistance.


Linda T. Vahdat, MD

Linda Vahdat is Chief of Cancer Services at the Memorial Sloan Kettering Cancer Center Norwalk Hospital Partnership in the greater New York City area. Previously she was Professor of Medicine and Director of the Breast Cancer Research Program at Weill Cornell Medical College. She has performed clinical and translational research in breast cancer for more than 20 years with a focus on new therapies in patients with high risk of relapse and metastatic disease. She has led several cancer drug development efforts, including two approved by the FDA. Dr. Vahdat has published over 100 peer-reviewed articles.

Back To Top